Literature DB >> 29027533

Factors associated with circulating concentrations of irisin in the general population cohort of the ABCD study.

S Buscemi1, D Corleo1, S Vasto2,3, C Buscemi1, M F Massenti4, D Nuzzo3, G Lucisano5, A M Barile1, G Rosafio1, V Maniaci1, C Giordano1.   

Abstract

OBJECTIVE: Animal studies have shown that irisin is a myokine secreted following physical exercise, and that it induces the remodeling of white adipose tissue toward brown adipose tissue. Therefore, a protective role of irisin against obesity, diabetes, and other metabolic and cardiovascular conditions has been hypothesized. However, data in humans are contradictory and few data are available concerning the general population.
DESIGN: We aimed to evaluate the association between serum irisin concentrations and habitual physical activity, as well as other metabolic and cardiovascular factors in a general population in a Mediterranean area.
METHODS: We considered 858 consecutive individuals included in the ABCD (Alimentazione, Benessere Cardiovascolare e Diabete) study (ISRCTN15840340), a longitudinal observational single-center study of a cohort representative of the general population of Palermo, Sicily. Irisin serum concentrations (Phoenix Europe, Germany), habitual physical activity (HPA) level, and other blood and clinical variables were measured.
RESULTS: The irisin serum concentrations were not normally distributed in the cohort (Shapiro-Wilk test=0.94; P<0.001). A significant association between irisin concentrations and HPA was observed (P<0.001). Irisin concentrations were higher in women than in men (P<0.01), and significantly correlated with serum concentrations of HDL-cholesterol (P<0.05) and hs-C-reactive protein (hs-CRP; P<0.05). Binary logistic regression analysis demonstrated that high (⩾ median value) irisin serum concentrations were significantly associated with female gender (OR=1.63; 95% CI=1.16-2.28), high serum hs-CRP concentrations (OR=1.61; 95% CI=1.02-2.54) and the HPA level (OR=1.42; 95% CI=1.02-1.96).
CONCLUSIONS: Our study confirms, in a cohort of a general population, that irisin concentrations gradually increase with the usual level of habitual physical activity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29027533     DOI: 10.1038/ijo.2017.255

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  52 in total

1.  Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry.

Authors:  Mark P Jedrychowski; Christiane D Wrann; Joao A Paulo; Kaitlyn K Gerber; John Szpyt; Matthew M Robinson; K Sreekumaran Nair; Steven P Gygi; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2015-08-13       Impact factor: 27.287

2.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

3.  Bioelectrical characteristics of type 1 and type 2 diabetic subjects with reference to body water compartments.

Authors:  S Buscemi; G Blunda; R Maneri; S Verga
Journal:  Acta Diabetol       Date:  1998-12       Impact factor: 4.280

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Plasma irisin levels progressively increase in response to increasing exercise workloads in young, healthy, active subjects.

Authors:  Stella S Daskalopoulou; Alexandra B Cooke; Yessica-Haydee Gomez; Andrew F Mutter; Andreas Filippaios; Ertirea T Mesfum; Christos S Mantzoros
Journal:  Eur J Endocrinol       Date:  2014-06-11       Impact factor: 6.664

6.  Serum levels of the myokine irisin in relation to metabolic and renal function.

Authors:  Thomas Ebert; Denise Focke; David Petroff; Ulrike Wurst; Judit Richter; Anette Bachmann; Ulrike Lössner; Susan Kralisch; Jürgen Kratzsch; Joachim Beige; Ingolf Bast; Matthias Anders; Matthias Blüher; Michael Stumvoll; Mathias Fasshauer
Journal:  Eur J Endocrinol       Date:  2014-03-08       Impact factor: 6.664

7.  Lower circulating irisin is associated with type 2 diabetes mellitus.

Authors:  Jian-Jun Liu; Melvin D S Wong; Wan Ching Toy; Clara S H Tan; Sylvia Liu; Xiao Wei Ng; Subramaniam Tavintharan; Chee Fang Sum; Su Chi Lim
Journal:  J Diabetes Complications       Date:  2013-04-22       Impact factor: 2.852

8.  Endurance training-induced increase in circulating irisin levels is associated with reduction of abdominal visceral fat in middle-aged and older adults.

Authors:  Eri Miyamoto-Mikami; Koji Sato; Toshiyuki Kurihara; Natsuki Hasegawa; Shumpei Fujie; Satoshi Fujita; Kiyoshi Sanada; Takafumi Hamaoka; Izumi Tabata; Motoyuki Iemitsu
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

9.  FNDC5/irisin is not only a myokine but also an adipokine.

Authors:  Arturo Roca-Rivada; Cecilia Castelao; Lucía L Senin; María O Landrove; Javier Baltar; Ana Belén Crujeiras; Luisa María Seoane; Felipe F Casanueva; María Pardo
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

10.  Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.

Authors: 
Journal:  Lancet       Date:  2016-04-06       Impact factor: 79.321

View more
  14 in total

Review 1.  Irisin is an Effector Molecule in Exercise Rehabilitation Following Myocardial Infarction (Review).

Authors:  Shuguang Qin; Zhenjun Tian; Maxime Boidin; Benjamin J R Buckley; Dick H J Thijssen; Gregory Y H Lip
Journal:  Front Physiol       Date:  2022-06-29       Impact factor: 4.755

2.  Association of Circulating Irisin Levels with Adiposity and Glucose Metabolic Profiles in a Middle-Aged Chinese Population: A Cross-Sectional Study.

Authors:  Ruibin Zhang; Tingting Fu; Xin Zhao; Yao Qiu; Xiaolin Hu; Hongyan Shi; Xiao Yin
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-30       Impact factor: 3.168

3.  Serum Irisin, Adropin, and Preptin in Obese Patients 6 Months After Bariatric Surgery.

Authors:  M Glück; J Glück; M Wiewióra; B Rogala; J Piecuch
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

4.  Association between Circulating Irisin and C-Reactive Protein Levels: A Systematic Review and Meta-Analysis.

Authors:  Elham Eslampour; Farzad Ebrahimzadeh; Amir Abbasnezhad; Mohammad Zeinali Khosroshahi; Razieh Choghakhori; Omid Asbaghi
Journal:  Endocrinol Metab (Seoul)       Date:  2019-06

5.  Fibroblast Growth Factor 21, Adiponectin, and Irisin as Markers of Unfavorable Metabolic Features in 12-Year-Old Children.

Authors:  Satu Seppä; Sirpa Tenhola; Raimo Voutilainen
Journal:  J Endocr Soc       Date:  2019-02-15

Review 6.  Brown and Brite: The Fat Soldiers in the Anti-obesity Fight.

Authors:  Shireesh Srivastava; Richard L Veech
Journal:  Front Physiol       Date:  2019-01-30       Impact factor: 4.566

7.  Influence of Habitual Dairy Food Intake on LDL Cholesterol in a Population-Based Cohort.

Authors:  Silvio Buscemi; Davide Corleo; Carola Buscemi; Cristiana Randazzo; Antonio Maria Borzì; Anna Maria Barile; Giuseppe Rosafio; Marcello Ciaccio; Rosalia Caldarella; Francesco Meli; Salvatore Maestri; Walter Currenti; Raffaele Ivan Cincione; Paolo Murabito; Fabio Galvano
Journal:  Nutrients       Date:  2021-02-11       Impact factor: 5.717

8.  Cardiometabolic health, visceral fat and circulating irisin levels: results from a real-world weight loss study.

Authors:  T Miazgowski; A Kaczmarkiewicz; B Miazgowski; J Kopeć
Journal:  J Endocrinol Invest       Date:  2020-09-06       Impact factor: 4.256

9.  Irisin and markers of metabolic derangement in non-diabetic Caucasian subjects with stage I-II obesity during early aging.

Authors:  Jonica Campolo; Ettore Corradi; Alice Rizzardi; Marina Parolini; Cinzia Dellanoce; Maria Luisa Di Guglielmo; Patrizia Tarlarini; Marina Cattaneo; Maria Giovanna Trivella; Renata De Maria
Journal:  PLoS One       Date:  2020-02-18       Impact factor: 3.240

10.  The association of circulating irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study.

Authors:  Lizhi Tang; Yuzhen Tong; Fang Zhang; Guilin Chen; Yun Cong Zhang; John Jobin; Nanwei Tong
Journal:  BMC Endocr Disord       Date:  2019-12-27       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.